Cotecna Group, a leading provider of Testing, Inspection and Certification services, has acquired Energon Labs, a cGMP-compliant, USFDA-inspected analytical testing laboratory based in Hyderabad, India. The move significantly strengthens Cotecna's global Life Sciences platform and expands its pharmaceutical testing capabilities across the Pharmaceutical, Biopharmaceutical, Medical Device and Packaging sectors.
The acquisition matters because it positions Cotecna to capitalize on India's rapidly growing pharmaceutical market, which is one of the world's fastest-growing and a critical manufacturing hub for global healthcare supply chains. By integrating Energon's specialized scientific talent, advanced laboratory infrastructure, and established presence in Hyderabad—a leading pharmaceutical and biotechnology hub—Cotecna gains immediate access to a well-established ecosystem and can better support both Indian and international customers with high-quality, regulatory-compliant testing services.
Energon serves customers across India, the United States, Asia-Pacific, and the Middle East and is recognized for its scientific excellence, regulatory expertise, and commitment to quality. Its comprehensive portfolio includes analytical method development and validation, stability studies, impurity profiling, extractables and leachables, glass delamination studies, peptides and oligonucleotide characterisation, raw material and finished product testing, in-vitro binding studies, packaging compatibility studies, and regulatory support services. These capabilities complement Cotecna's existing pharmaceutical testing network, which includes Cotecna Life Sciences, Shiva Analyticals, and Neotron Pharma, enhancing the Group's ability to support customers throughout the product lifecycle and address evolving global quality, compliance, and regulatory requirements.
Sebastien Dannaud, Chief Executive Officer of Cotecna Group, said, “We are pleased to welcome Energon Labs to the Cotecna Group. This acquisition represents another important step to support our ambition to become one of the largest providers of Life Sciences testing services in India, and strengthens our position in one of the world's most important pharmaceutical markets.”
Amit Chopra, CEO South Asia and Middle East, Cotecna Group, added, “I am delighted to welcome Manikanth Reddy and the talented team of Energon Labs to the Cotecna group. This acquisition aligns perfectly with our strategy of building a comprehensive pharmaceutical testing ecosystem across key growth markets.”
Manikanth Reddy, Founder of Energon, commented, “Joining the Cotecna Group opens an exciting new chapter for Energon Labs. Becoming part of a global organization like Cotecna provides new opportunities to expand our capabilities, strengthen our service offerings and deliver even greater value to our customers.”
The acquisition enhances Cotecna's ability to deliver greater responsiveness, scalability, and operational efficiency across key markets, reinforcing its position as a trusted partner to pharmaceutical manufacturers serving regulated markets worldwide. The original release is available via www.newmediawire.com.
